Genetics of Late Radiotherapy Damage in Breast Cancer Patients
Author Information
Author(s): Giotopoulos G, Symonds R P, Foweraker K, Griffin M, Peat I, Osman A, Plumb M
Primary Institution: University of Leicester
Hypothesis
What are the genetic factors contributing to late normal tissue radiation injury in breast cancer patients?
Conclusion
The study found that distinct genetic factors contribute to different types of late radiation injuries in breast cancer patients.
Supporting Evidence
- 8% of patients homozygous for the TGFβ1 (C-509T) variant allele have a 15-fold increased risk of fibrosis.
- An early acute reaction to radiation increases the risk of long-term fibrosis by an odds ratio of 8.5.
- The XRCC1 (R399Q) polymorphism is associated with an increased risk of telangiectasia.
Takeaway
Some people get hurt in different ways after radiation treatment for breast cancer, and this study looks at how genes might play a role in that.
Methodology
Patients were genotyped for SNPs in eight candidate genes and assessed for late normal tissue damage using SOMA and RTOG scales.
Potential Biases
Multiple testing on the same patient samples may lead to false positive or negative results.
Limitations
The sample size is relatively small, which may reduce the statistical power of the findings.
Participant Demographics
The majority of participants were Caucasian, with some of Asian and African Caribbean descent.
Statistical Information
P-Value
0.000003
Confidence Interval
95% CI: 3.76–60.3
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website